IPMN, PANCREATIC
Clinical trials for IPMN, PANCREATIC explained in plain language.
Never miss a new study
Get alerted when new IPMN, PANCREATIC trials appear
Sign up with your email to follow new studies for IPMN, PANCREATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Three-Pronged attack aims to stop dangerous leaks after pancreas surgery
Disease control Recruiting nowThis international trial is testing a combination of three existing treatments to reduce serious complications after a major surgery to remove pancreatic tumors. The bundle includes two short-term medications and a surgical patch, all given around the time of surgery. The goal is…
Matched conditions: IPMN, PANCREATIC
Phase: PHASE4 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Scientists hunt for clues to prevent unnecessary pancreas surgery
Diagnosis Recruiting nowThis study aims to find better ways to tell which pancreatic cysts are harmless and which might turn into cancer. Researchers will analyze samples from 800 people with these cysts, looking for patterns in their genes, environment, and body chemistry. The goal is to create a new t…
Matched conditions: IPMN, PANCREATIC
Sponsor: IRCCS San Raffaele • Aim: Diagnosis
Last updated Mar 27, 2026 12:38 UTC
-
AI vs. doctors: the battle to spot pancreatic cancer
Diagnosis Recruiting nowThis study is testing a new artificial intelligence (AI) system designed to help doctors diagnose and manage pancreatic diseases from CT scans. It will compare the AI's recommendations for surgery or monitoring against the decisions of experienced doctors in 2,000 patients. The m…
Matched conditions: IPMN, PANCREATIC
Sponsor: Changhai Hospital • Aim: Diagnosis
Last updated Mar 23, 2026 15:29 UTC
-
Hunt for clues to stop pancreatic cancer before it starts
Knowledge-focused Recruiting nowThis study aims to find better biological markers to predict which pancreatic cysts (called IPMNs) are likely to turn into cancer. Researchers will analyze tissue and blood samples from 3600 patients to understand the differences between low-risk and high-risk cysts. The goal is …
Matched conditions: IPMN, PANCREATIC
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC